<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR32">
 <label>32.</label>
 <mixed-citation publication-type="other">Maiti S et al (2020) Active-site molecular docking of Nigellidine to nucleocapsid/Nsp2/Nsp3/MPro of COVID-19 and to human IL1R and TNFR1/2 may stop viral-growth/cytokine-flood, and the drug source 
  <italic>Nigella sativa</italic> (black cumin) seeds show potent antioxidant role in experimental rats. J Drug Target 27(19):245–251  
 </mixed-citation>
</ref>
